Literature DB >> 16697263

Psychiatric comorbidity in adult patients with hypothalamic hamartoma.

Sherese Ali1, John Moriarty, Nandini Mullatti, Anthony David.   

Abstract

The objective was to investigate the prevalence of psychiatric comorbidity in adults with hypothalamic hamartoma (HH). A standardized clinical interview and assessment scales were used to assess for depression, anxiety, personality, and sexual behavior, based on previous findings in the pediatric population. We found a high prevalence of mood and anxiety disorders, with Major Depressive Disorder and Social Anxiety Disorder being the most common. "Anxious" personality types were the most common. Symptoms of Asperger syndrome were high in males versus females. We concluded that depression and anxiety are common in adult patients with HH. Remission of cognitive, behavioral, and autistic symptoms has been reported with surgical tumor resection. Whether this can correct the psychiatric disturbances remains to be investigated. The need for adjunctive psychiatric treatment may nevertheless remain.

Entities:  

Mesh:

Year:  2006        PMID: 16697263     DOI: 10.1016/j.yebeh.2006.03.016

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Psychiatric features in gelastic epilepsy and hypothalamic hamartoma: long-term psychodiagnostic observations.

Authors:  Luca Errichiello; Pasquale Striano; Diana Galletta; Salvatore Striano
Journal:  Neurol Sci       Date:  2014-03       Impact factor: 3.307

2.  Superficial siderosis of the central nervous system: A case report.

Authors:  Ji-Guo Gao; Chun-Kui Zhou; Jing-Yao Liu
Journal:  Exp Ther Med       Date:  2015-01-28       Impact factor: 2.447

3.  A case of pure gelastic seizures due to hypothalamic hamartoma with a benign course.

Authors:  T D Gosavi; M C Walker
Journal:  Epilepsy Behav Case Rep       Date:  2017-06-16

Review 4.  Hypothalamic Hamartomas: Evolving Understanding and Management.

Authors:  Nathan T Cohen; J Helen Cross; Alexis Arzimanoglou; Samuel F Berkovic; John F Kerrigan; Ilene Penn Miller; Erica Webster; Lisa Soeby; Arthur Cukiert; Dale K Hesdorffer; Barbara L Kroner; Clifford B Saper; Andreas Schulze-Bonhage; William D Gaillard
Journal:  Neurology       Date:  2021-10-04       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.